The changes add several lower-priced countries to the basket of those to which Canada’s prices must be compared to determine the maximum permissible price, while removing the U.S. and Switzerland from the mix to lower the price ceiling.When there is uncertainty, businesses of any kind have to assume and prepare for the worst.
This is especially true when investing billions of dollars in very risky multi-year projects to develop and launch new medicines around the world. And if one country creates a uniquely unfavourable and uncertain business environment, it will quickly become less competitive in attracting highly coveted investments and new medical innovations.Enjoy unlimited website access and the digital newspaper.
Мы обобщили эту новость, чтобы вы могли ее быстро прочитать.Если новость вам интересна, вы можете прочитать полный текст здесь Прочитайте больше: